Unrealistic optimism in early-phase oncology trials

IRB Ethics and Human Research

Volumn 33, Issue 1, 2011, Pages 1-8

  Jansen, Lynn A ^a   Appelbaum, Paul S ^b   Klein, William M P ^c   Weinstein, Neil D ^d   Cook, William ^e   Fogel, Jessica S ^b   Sulmasy, Daniel P ^f  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Columbia University ^*  (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^e ST VINCENT S COMPREHENSIVE CANCER CENTER   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; ETHICS; FEMALE; HISTORY; HUMAN; INFORMED CONSENT; MALE; MIDDLE AGED; NEOPLASM; PATIENT; PHASE 1 CLINICAL TRIAL (TOPIC); PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RISK ASSESSMENT; SOCIAL PSYCHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; CLINICAL TRIALS AS TOPIC; CLINICAL TRIALS, PHASE I AS TOPIC; FEMALE; HISTORY, 18TH CENTURY; HUMANS; INFORMED CONSENT; MALE; MIDDLE AGED; NEOPLASMS; PATIENTS; PREJUDICE; QUESTIONNAIRES; RISK ASSESSMENT;

EID: 79951822397     PISSN: 01937758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Agrawal M, Emanuel EJ. Ethics of phase I oncology trials: Reexamin- ing the arguments and the data. JAMA 2003; 290(8): 1075-1082;
2. Miller FG and Joffe S. Benefit in phase i oncology trials: Therapeutic misconception or reasonable treatment option? Clinical Trials 2008; 5: 617-623.
3. Appelbaum PS, Roth H, Lidz CW, et al. False hopes and best data: Consent to research and the therapeutic misconception. Hastings Center Report 1987; 12(2): 20-24;
4. Daugherty C, Ratin MJ, Grochowski E, et al. Perceptions of cancer patients and their physicians involved in phase I trials. Clinical Oncology 1995; 13(5): 1062-1072;
5. Horng S, Grady C. Misunderstanding in clinical research: Distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism. IRB: Ethics & Human Research 2003; 25(2): 11-16.
6. See ref. 2, Appelbaum et al. 1987. As commonly defined, the therapeutic misconception is the "belief of patient-subjects that even in a research setting the principle of personal care will still apply."
7. See Berg JW, Appelbaum PS, Parker LS, and Lidz CW. Informed Consent: Legal Theory and Clinical Practice, 2nd ed. New York: Oxford University Press, 2001, p. 288. Patientsubjects thus confuse the purpose of clinical research with the purpose of therapeutic medicine.
8. See also the definition proposed in Henderson GE, Churchill LR, Davis AM, et al. Clinical trials and medical care: Defining the therapeutic misconception. PLoS Medicine 2007; 4(11): 1735-1738. This is how we understand the term in this paper. However, in recent years, broader definitions or characterizations of the therapeutic misconception have been proposed.
9. See, in particular, Appelbaum PS, Lidz CW, Grisso T. Therapeutic misconception in clinical research: Frequency and risk factors. IRB: Ethics & Human Research 2004; 26(2): 1-8.
10. Wendler D, Krohmal B, Emanuel EJ, et al. Why patients continue to participate in clinical research. Archives of Internal Medicine 2008; 168(12): 1294-1299;
11. Jansen L. The ethics of altruism in clinical research. Hastings Center Report 2009; 39(4): 26-36.
12. See ref. 2, Horng and Grady 2003;
13. Agrawal M, Grady C, Fairclough DL, et al. Patients' decision-making process regarding participation in phase I oncology research. Journal of Clinical Oncology 2006; 24(7): 4479-4484;
14. Weinfurt KP, Seils DM, Tzeng, JP, et al. Expectations of benefit in early-phase clinical trials: Implications for assessing the adequacy of informed consent. Medical Decision Making 2008; 28(4): 575581.
15. See ref. 2, Horng and Grady 2003.
16. Cohen L, de Moor C, Amato RJ. The association between treatment-specific optimism and depressive symptomatolgy in patients enrolled in a phase I cancer clinical trial. Cancer 2001; 91(10): 1949-1955. (Pubitemid 32424123)
17. Helft PR, Hlubocky F, Wen M, Daugherty CK. Associations among awareness of prognosis, hopefulness, and coping in patients with advanced cancer participating in phase I clinical trials. Supportive Care in Cancer 2003; 11: 644-651. (Pubitemid 37243595)
18. Jansen LA. The problem with optimism in clinical trials. IRB: Ethics & Human Research 2006; 28(4): 13-19. (Pubitemid 44358619)
19. Weinstein ND. Unrealistic optimism about future life events. Journal of Personality and Social Psychology 1980; 39: 806-820;
20. Weinstein ND. Unrealistic optimism about susceptibility to health problems. Journal of Behavioral Medicine 1982; 5(4): 441-460;
21. Segerstrom SC, McCarthy WJ, Caskey NH, et al. Optimistic bias among cigarette smokers. Journal of Applied Social Psychology 1993; 23: 1606-1618;
22. Barnoy S, Bar-Tal Y, Treister L. Effect of unrealistic optimism, perceived control over disease, and experience with female cancer on behavioral intentions of Israeli women to undergo screening tests. Cancer Nursing 2003; 26(5): 369;
23. Dillard AJ, Midboe A, Klein WM. The dark side of optimism: Unrealistic optimism about problems with alcohol predicts subsequent negative event experiences. Personality and Social Psychology Bulletin 2009; 35: 15401550.
24. Radcliffe NM, Klein WMP. Dispo- sitional, unrealistic, and comparative optimism: Differential relations with the knowledge and processing of risk information and beliefs about personal risks. Personality and Social Psychology Bulletin 2002; 28: 836-846. (Pubitemid 41269844)
25. Weinstein ND. Optimistic biases about personal risks. Science 1989; 246: 12321233.
26. One might think that patient-subjects in early-phase oncology trials could know that they are more likely to benefit than others since they have met the inclusion criteria for the trials. But even if this were true, patient-subjects could be asked to compare themselves to others who are enrolled in similar trials and so also have met the inclusion criteria.
27. See ref. 10, Weinstein 1980.
28. See ref. 10, Weinstein 1982.
29. Weinstein ND, Klein WMP. Unrealistic optimism: Present and future. Journal of Science and Clinical Psychology 1996; 15: 18;
30. see ref. 12, Weinstein 1989;
31. see ref. 10, Weinstein 1980.
32. Prior to the study a power analysis was conducted to determine an appropriate sample size. The power analysis was based on the level of unrealistic optimism typically observed in past research on the bias.
33. For events designated as "existing drugs," "cancer controlled," "health benefit," and "cancer cured," a positive mean score indicates an optimistic bias. For the event designated "health problem," a negative mean score indicates an optimistic bias.
34. Radcliffe NM, Klein WMP. Dispositional, unrealistic, and comparative optimism: Differential relations with the knowledge and processing of risk information and beliefs about personal risks. Personality and Social Psychology Bulletin 2002; 28: 836-846. (Pubitemid 41269844)
35. See ref. 10, Dillard, Midboe, and Klein 2009.
36. Grisso T, Appelbaum PS. Assessing Competence to Consent to Treatment. New York: Oxford University Press, 1998, p. 44.
37. See ref. 9, Jansen 2006.
38. Elster J. Sour Grapes: Studies in the Subversion of Rationality. Cambridge, MA: Cambridge University Press, 1991.
39. Feinberg J. Harm to Self. New York: Oxford University Press, 1986;
40. Hart HLA. Punishment and Responsibility. Oxford, UK: Clarendon Press, 1968. For an alternative view,
41. see Appelbaum PS, Lidz CW, Klitzman R. Voluntariness of consent to research: A conceptual model. Hastings Center Report 2009; 39(1): 30-39.
42. Taylor SE, Brown JD. Illusion and well-being: A social-psychological perspective on mental health. Psychological Bulletin 1988; 103: 193-210;
43. Armor DA, Taylor SE: When predictions fail: The dilemma of unrealistic optimism. In Gilovich T, Griffin D, Kahneman D, eds. Heuristics and Biases: The Psychology of Intuitive Judgment. Cambridge, MA: Cambridge University Press, 2002, pp. 334-347.
44. See ref. 7, Cohen et al. 2001.
45. Kreuter MW, Strecher VJ. Do tailored behavior change messages enhance the effectiveness of health risk appraisal? Results from a randomized trial. Health Education Research 1996; 11:95-105;
46. see ref. 19, Radcliffe and Klein 2002; Gold RS, Aucote HM. I'm less at risk than most guys: Gay men's unrealistic optimism about becoming infected with HIV. International Journal of STD & AIDS 2003; 14: 18-13;
47. see ref. 10, Barnoy et al. 2003.
48. Klein WMP, Cooper KL. On the physical costs of self-enhancement. In Chang E, ed., Self-Enhancement and Self-Criticism. Washington, DC: American Psychological Association, 2007.